- NASDAQ TRADE HALT CONTINUES <TBCVU.O> REASON NOT AVAILABLE AT 09:05 AM
- Parker Hannifin completes acquisition of Filtration Group Corp
- Arizona Gold & Silver hits 21.79 meters at 4.1 g/t gold at Philadelphia project in Arizona
- TerraVest FY26 Q3 net income more than doubled to $35,604; sales rise 14% to $460,894
- Interlink Electronics Q2 FY26 net income rises to $248,000; revenue increases 10% to $3.77 million
- Janus Henderson cuts Bike24 voting rights stake to 0% from 7.83%
- T. Rowe Price names Agrawal to lead expanded Investment AI Solutions unit
- STAAR SURGICAL COMPANY <STAA.O>: UBS CUTS TARGET PRICE TO $19 FROM $20
- Thunderstruck Resources prices non-brokered private placement at $0.15/share to raise $1.8 million
- ACCENDRA HEALTH INC : UBS CUTS TARGET PRICE TO $1.5 FROM $4.5
- JACK IN THE BOX INC <JACK.O>: UBS RAISES TARGET PRICE TO $20 FROM $14
- KONTOOR BRANDS, INC. <KTB.N>: UBS RAISES TARGET PRICE TO $136 FROM $131
- PACKAGING CORP OF AMERICA : UBS RAISES TARGET PRICE TO $292 FROM $271
- XYLEM INC <XYL.N>: UBS RAISES TARGET PRICE TO $138 FROM $135
- ASSURANT INC : UBS RAISES TARGET PRICE TO $331 FROM $274
- CISCO SYSTEMS INC <CSCO.O>: UBS RAISES TARGET PRICE TO $138 FROM $132
- BRINKER INTERNATIONAL INC <EAT.N>: UBS RAISES TARGET PRICE TO $285 FROM $260
- GOODRX HOLDINGS, INC. <GDRX.O>: UBS RAISES TARGET PRICE TO $3.75 FROM $2.5
- RMX net loss more than doubles to USD 11.05 million in Q2 FY26; revenue drops 89% to USD 1,440
- BRP to host Q2 FY2027 results conference call
- TerraVest declares quarterly dividend of $0.20 per share
- OptimumBank raises annual EPS outlook to about $1-$1.15
- Cyabra Q2 FY26 net loss widens 41% to USD 3.44 million; revenue rises 39% to USD 1.85 million
- Silver Hammer completes 2026 surface exploration program at Eliza silver project in Nevada
- Emerson wins multi-million-dollar BP Shah Deniz Compression automation contract
- Qualstar Q2 FY26 net loss widens to $1.1 million; revenue rises 47% to $2.1 million
- Marsh McLennan’s Mercer forms strategic alliance with Compa on AI-driven compensation insights
- HCA’s Sarah Cannon Research Institute partners with Merck to expand access to oncology clinical trials in US communities
- Clutter by Iron Mountain relaunches premium managed personal storage service
- Comstock Q2 FY26 net income more than doubled to $8.85 million; revenue rises 74% to $22.58 million
- Credit Acceptance names ex-Amazon AI executive Jeetu Mirchandani as CTO
- nCino partners with Dun & Bradstreet to integrate D&B Commercial Graph into client lifecycle management platform
- BRINKER INTERNATIONAL INC <EAT.N>: JP MORGAN RAISES TARGET PRICE TO $250 FROM $190
- Lifeway Foods Q2 FY26 net income turns to USD 0.1 million; net sales rise 24.1% to USD 66.9 million
- Market pricing indicates that bets on the Federal Reserve keeping rates unchanged in September have increased. The probability of the Federal Reserve maintaining rates in the 3.50%-3.75% range in September is around 65%, up from about 60% before the release of the PPI report.
- NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:00 AM
- NASDAQ TRADE HALT CONTINUES <QMMM.O> REASON NOT AVAILABLE AT 09:00 AM
- NASDAQ TRADE HALT CONTINUES <SVA.O> REASON NOT AVAILABLE AT 09:00 AM
- NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:00 AM
- Dow Jones Top Markets Headlines at 9 AM ET: U.S. Producer-Price Index Unchanged in July | U.S. ...
- Saga Communications 2Q Rev $26.4M >SGA
- Saga Communications 2Q Net $960,000 >SGA
- Saga Communications 2Q EPS 15c >SGA
- CARRIAGE SERVICES INC <CSV.N>: OPPENHEIMER INITIATES COVERAGE WITH OUTPERFORM RATING AND TARGET PRICE $48
- Federal Reserve official Harker recently stated: "The Fed must raise interest rates now because current policy is not restrictive, and recent shocks have driven inflation higher. Rapid growth could put additional pressure on prices. Raising rates may be painful, but we cannot allow economic growth and investment to become excessive to the point where the economy overheats. Current inflation is widespread and not limited to just certain sectors. The Fed must be accountable for inflation data, an
- Goldcana Resources announces 2-for-1 stock split, shares to double to 22,536,000
- CSN Mineracao posts 2Q26 net income of R$ 219 million, up 89% y/y
- Boa Acquisition Corp II units to split into Nasdaq-listed shares, rights on Aug. 14
- Yue Ying: August 13 Bitcoin and Ethereum Market Analysis - Continue to Wait for Direction at a Slow Pace, Short-term Strategies Included
- Frontier Lithium proposes amendments to $3.35 million convertible loan, extends maturity 18 months
- BRIEF-Biofrontera Q2 Revenue USD 12 Million
- Biofrontera 2Q Loss/Shr 5c >BFRI
- Federal Reserve's Barkin: Employment continues to support household consumption, while those who own real estate or stocks have enjoyed "significant" wealth growth.
- Biofrontera Q2 FY26 net loss narrows to $0.6 million; revenue rises 32.9% to $12 million
- Federal Reserve's Barkin: Given that compensation pressure is moderate, and tariffs, oil, and other shocks may subside, there is sufficient reason to believe that inflation will ease.
- Federal Reserve's Harker: The Fed must be accountable to a single inflation data point, and this is very important.
- BRIEF-Frontier Lithium Announces Proposed Amendments To Convertible Loan
- Solstad Maritime signs LOI for Normand Cutter subsea support contract starting late 2026/early 2027
- Novus lifts Mustek stake to 56.86% in voting rights disclosure
- Poland’s June current account deficit far exceeds expectations, hitting a near one-year high
- Ategrity Specialty Q2 FY26 net income attributable to stockholders rises 89.8% to $33.45 million
- ADC Therapeutics posts corporate presentation highlighting Zynlonta growth opportunity in B-cell lymphomas
- OS Therapies wins FDA Type C meeting to review 2.5-year survival data for OST-HER2 Phase 2b osteosarcoma trial
- BRIEF-Orbit International Q2 EPS USD -0.51
- Copel declares BRL 706 million interest on equity, payable Sept. 30
- KOIL Energy Q2 FY26 net income rises to $652,000; revenue climbs 78% to $9.2 million
- Orbit International Q2 FY26 net loss widens to $1.72 million; net sales fall to $4.89 million
- Orbit International 2Q Sales $4.89M >ORBT
- TABLE - US Labor Dept. jobless claims data
- Montega raises Cantourage price target to EUR 10, reiterates buy rating
- PLDT 1H FY26 net income falls 6% to PHP 16.53 billion; revenue rises 2% to PHP 112.01 billion
- Ultrapar joins Dow Jones Best-in-Class Emerging Markets Index for first time
- US July PPI MoM: 0%, expected 0.20%, previous value revised from -0.30% to -0.1%.
- Spot gold has just surpassed the $4,390.00/ounce mark, last quoted at $4,389.42/ounce, down 0.43% on the day; COMEX gold futures main contract last quoted at $4,447.20/ounce, down 0.45% on the day.
- 1RT Acquisition swings to Q2 FY26 net income of $1.43 million
- US July PPI annual rate is 4.7%, expected 4.9%, previous value 5.50%.
- After the data release, spot gold jumped $15 in the short term to $4410, but has now fallen back to $4386 (-0.51%).
- US July producer prices data
- Brenmiller Energy rebrands as BrenX, plans Nasdaq ticker change to BRNX
- TABLE-US July producer prices data
- Apollo posts investor presentation outlining integrated asset management, retirement services strategy, USD 1 trillion AUM milestone
- US July producer prices data
- US July producer prices data
- Suzano targets stronger pulp sales in 2H26 on seasonal demand, higher output availability
- US jobless claims data
- SAIC schedules fiscal 2027 second-quarter earnings call
- Maersk starts DKK 3.15 billion share buyback second phase
- US jobless claims data
- PDS Biotechnology 2Q Loss $9.75M >PDSB
- Dogwood Therapeutics 2Q Loss/Shr 34c >DWTX
- Ovid Therapeutics 2Q Rev $733,000 >OVID
- Innovative Solutions 3Q Sales $26.7M >ISSC
- Dogwood Therapeutics: Halneuron Phase 2b Trial in Chemotherapy Induced Neuropathy on Track for Top-Line Results in Fall 2026, 217 Patients Enrolled >DWTX
- Ovid Therapeutics 2Q Research and Development Expenses $10.0M >OVID
- Lamar Advertising Acquires Assets of AdSource Outdoor in UPREIT Transaction
- Fate Therapeutics 2Q Rev $2.08M >FATE
- Nakamoto 2Q Loss/Shr $6.65 >NAKA
- Fate Therapeutics 2Q Loss/Shr 25c >FATE
- What makes a good crypto trader? — AMA recap with Paradyze
- Bitcoin Dominance Remains Overdue for a Huge Decline as Altcoin Market Undergoes a Massive Reset
